Blueberries Medical, a Latin American licensed producer of medicinal cannabis and cannabis-derived products, has announced a non-brokered private placement, to raise approximately CA$1.9m ($1.4m). The company announced the sale of 180,716,00 common shares at CA$0.011 per share. The net proceeds from the sale will be used to repay existing debt and for general corporate and working capital purposes. The offering was led by Terraflos, a Latin American company founded and controlled by Facundo Garreton, who serves as Blueberries' chairman, CEO, and director. Terraflos is exploring opportunities in Argentina, Mexico, and Brazil and plans to expand into those markets in the near future.
Related Keywords
United States , Mexico , Argentina , Brazil , America , American , Benzinga Potprofits , Facundo Garreton , Michael Berger , Terraflos Inc , Latam Cannabis Co , Blueberries Medical Corp , Blueberries Medical , Latin America , Latam Cannabis , Founded By Former Congressman , Seed Funding , Allied Corp ,
vimarsana.com © 2020. All Rights Reserved.